Study Title: Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study
For more information about the trial above please contact the study team:Medical University of South CarolinaAffiliate Principal Investigator, Lupak, Oleksandra, at lupak@musc.edu.Principal Investigator, Hess, Brian, at hessbr@musc.edu.Study Coordinator, Smith, Julia, at smijuli1@musc.edu.Ralph H. Johnson VAMCStudy Coordinator, Jeter, Kathy, at katherine.jeter2@va.gov.Trial opened at the following institutions: Ralph H. Johnson VAMC, Medical University of South Carolina